ghk cu dosage peptide GHK-Cu Calculator recommended ghk-cu dosage subcutaneous trt

Bottom Line BPC157 remains an experimental peptide with mechanistic plausibility derived from preclinical models but insufficient human data to claim clinical efficacy or long term safety, and its regulatory and anti doping status increase risk for patients and athletes considering unsupervised use

The labeled starting dose is 2.5 mg weekly for at least four weeks

As tirzepatide gradually clears from your system over 3 to 4 weeks, you may experience a transition period during which side effects evolve and your body readjusts to functioning without the medication's effects

Higher-frequency dosing: For advanced schedules, split the daily total across two or more injections rather than one large volume